CooperVision launches science and technology awards

Article

Two awards are being offered by CooperVision to foster exploration of technology advancement in ocular surface health and anterior segment symptomology.

Pleasanton, CA-CooperVision has begun a Science and Technology (S&T) Awards Program to bring recipients and CooperVision scientists together to explore new areas of technology advancement. The awards program will address ocular surface health and anterior segment symptomology through advancement of technologies including, but not limited to materials, devices and compounds.

“Our goal is to support science and encourage a focus on unmet needs that can be translated back to our community,” said Arthur Back, chief technology officer for CooperVision.

The CooperVision S&T Awards Program is comprised of two awards: First, the CooperVision Seedling Award provides funding for 1 year to incentivize collaborations with CooperVision in a new research area. The CooperVision Translational Research Award provides funding for up to 2 years for a substantive, innovative translational research project.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.